Tectonic Therapeutic (TECX) has had the highest return this year by a US stock, returning 5,611,150%.

ASSET	YEAR	% RETURN
Tectonic Therapeutic (TECX)	2024	5,611,150%
Nexalin Technology (NXLIW)	2024	7,647.89%
Iteris (ITI)	2024	5,315.5%
Wearable Devices (WLDSW)	2024	3,900%
Triller (ILLRW)	2024	3,178.69%
TSS, Inc Common Stock (TSSI)	2024	2,607.41%
GeneDx (WGS)	2024	2,569.26%
Bright Minds Biosciences (DRUG)	2024	2,073.15%
Sezzle Inc Common Stock (SEZL)	2024	2,024.05%
LENZ Therapeutics (LENZ)	2024	1,859.69%
GeneDx (WGSWW)	2024	1,635%
BM Technologies Inc WT (BMTX.WT)	2024	1,524.55%
Fitell Corporation Ordinary Shares (FTEL)	2024	1,469.08%
Zivo Bioscience (ZIVO)	2024	1,455.56%
NeoVolta Inc Warrant (NEOVW)	2024	1,311.41%
CompoSecure (CMPOW)	2024	1,160.53%
Mobiquity Technologies (MOBQ)	2024	1,100.58%
Monopar Therapeutics (MNPR)	2024	1,090.94%
Codere Online Luxembourg SA Warrants (CDROW)	2024	1,010.33%
Palladyne AI (PDYNW)	2024	999%
Root (ROOT)	2024	949.9%
Dave (DAVE)	2024	911.29%
Nexalin Technology (NXL)	2024	830.79%
Roth CH Acquisition V Co Warrant (ROCLW)	2024	814.54%
Core Scientific, Inc Tranche 2 Warrants (CORZZ)	2024	775%